449 related articles for article (PubMed ID: 30826330)
1. Inhibition of MMPs and ADAM/ADAMTS.
Malemud CJ
Biochem Pharmacol; 2019 Jul; 165():33-40. PubMed ID: 30826330
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.
Yang CY; Chanalaris A; Troeberg L
Osteoarthritis Cartilage; 2017 Jul; 25(7):1000-1009. PubMed ID: 28216310
[TBL] [Abstract][Full Text] [Related]
3. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
Zhong S; Khalil RA
Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
5. MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.
Li Y; Wang W; Li L; Khalil RA
Life Sci; 2020 Jul; 253():117659. PubMed ID: 32283055
[TBL] [Abstract][Full Text] [Related]
6. Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies.
Itoh Y
Prog Mol Biol Transl Sci; 2017; 148():327-338. PubMed ID: 28662826
[TBL] [Abstract][Full Text] [Related]
7. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease.
Cawston TE; Wilson AJ
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):983-1002. PubMed ID: 16980219
[TBL] [Abstract][Full Text] [Related]
8. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
Flannery CR; Little CB; Caterson B; Hughes CE
Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
[TBL] [Abstract][Full Text] [Related]
9. Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes -- possible pathogenic role in osteoarthritis.
Prasadam I; Crawford R; Xiao Y
J Rheumatol; 2012 Mar; 39(3):621-34. PubMed ID: 22247346
[TBL] [Abstract][Full Text] [Related]
10. Matrix-degrading metalloproteinases and their roles in joint destruction.
Okada Y
Mod Rheumatol; 2000 Sep; 10(3):121-8. PubMed ID: 24383588
[TBL] [Abstract][Full Text] [Related]
11. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
[TBL] [Abstract][Full Text] [Related]
12. Metalloproteinases: their role in arthritis and potential as therapeutic targets.
Clark IM; Parker AE
Expert Opin Ther Targets; 2003 Feb; 7(1):19-34. PubMed ID: 12556200
[TBL] [Abstract][Full Text] [Related]
13. ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.
Yang H; Khalil RA
Adv Pharmacol; 2022; 94():255-363. PubMed ID: 35659374
[TBL] [Abstract][Full Text] [Related]
14. [Progress of research in osteoarthritis. Metalloproteinases in osteoarthritis].
Okada A; Okada Y
Clin Calcium; 2009 Nov; 19(11):1593-601. PubMed ID: 19880991
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis.
Tsushima H; Okazaki K; Hayashida M; Ushijima T; Iwamoto Y
Ann Rheum Dis; 2012 Jan; 71(1):99-107. PubMed ID: 21917825
[TBL] [Abstract][Full Text] [Related]
17. The role of ADAMTSs in arthritis.
Lin EA; Liu CJ
Protein Cell; 2010 Jan; 1(1):33-47. PubMed ID: 21203996
[TBL] [Abstract][Full Text] [Related]
18. Proteinases and plaque rupture: unblocking the road to translation.
Newby AC
Curr Opin Lipidol; 2014 Oct; 25(5):358-66. PubMed ID: 25089553
[TBL] [Abstract][Full Text] [Related]
19. VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts.
Pérez-García S; Carrión M; Gutiérrez-Cañas I; González-Álvaro I; Gomariz RP; Juarranz Y
J Cell Mol Med; 2016 Apr; 20(4):678-87. PubMed ID: 26818776
[TBL] [Abstract][Full Text] [Related]
20. Expression of ADAMs and their inhibitors in sputum from patients with asthma.
Paulissen G; Rocks N; Quesada-Calvo F; Gosset P; Foidart JM; Noel A; Louis R; Cataldo DD
Mol Med; 2006; 12(7-8):171-9. PubMed ID: 17088949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
